In a new report, Ampronix looks at the rapid expansion of simulated procedures into medical education, including programs recently implemented for Baylor College and Tuoro University System.

Thirty-day data from the European post-approval study of the Edwards Sapien 3 transcatheter aortic heart valve demonstrated positive patient outcomes, including the lowest reported mortality and stroke rates seen in the SOURCE family of registries.

Edwards Lifesciences Corp. announced that a federal jury in Boston returned a verdict in favor of CardiAQ in a lawsuit filed against a former service provider, Neovasc.

A new technique for cardiac magnetic resonance (CMR) imaging improves accuracy by removing patients' need to breathe, reveals research presented at EuroCMR 2016.

cardiac rehab, cardiac rehabilitation, CHF, heart failure

Cardiac rehabilitation and exercise training has been shown to improve clinical status and outcomes in congestive heart failure (CHF) patients.[1] However, it is often difficult to get patients to engage with rehabilitation, exercise and lifestyle changes. Sinai-Grace Hospital (SGH) in Detroit offers the following patient case study to illustrate how rehabilitation programs can aid CHF patients who are willing to engage with them to improve their health.

First-in-human data presented at EuroPCR 2016 demonstrate that hemodynamic data from HeartFlow Inc. may help predict which coronary plaques have the potential to rupture.

Boston Scientific has received U.S. Food and Drug Administration (FDA) approval for two catheters that can be used with the Rhythmia Mapping System.

Mitralign Inc. announced it has raised $39.8 million to date in a Series E equity round of financing.

May 23, 2016 — In a guideline update published last week, the American College of Cardiology, American Heart Association and Heart Failure Society of America detail the groups’ recommendations for the use of two new heart failure medications.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now